CRP and COVID-19: The univariate analysis showed that the group of cerebrovascular patients infected with COVID-19 was characterized by more frequent diagnosis of LVO (p < 0.001), higher C-reactive protein (CRP) level (p = 0.002), higher 30-day mortality (p = 0.03), and lower hemoglobin level (HGB) (p = 0.015), white blood cells (WBC) (p = 0.014), and platelet counts (p = 0.04).